Complementary and alternative medicine in inflammatory bowel disease patients: Frequency and risk factors

Digestive and Liver Disease

Volumn 44, Issue 11, 2012, Pages 904-908

  Fernández, Alberto ^a   Barreiro de Acosta, Manuel ^b,c   Vallejo, Nicolau ^b,c   Iglesias, Marta ^c   Carmona, Amalia ^a   González Portela, Carlos ^a   Lorenzo, Aurelio ^b   Domínguez Muñoz, J Enrique ^b,c  

^a HOSPITAL POVISA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c FIENAD ^*  (Spain)

Author keywords

Alternative therapies; Complementary medicine; Crohn's disease; Ulcerative colitis

Indexed keywords

HERBACEOUS AGENT; IMMUNOSUPPRESSIVE AGENT; KEFIR;

ACUPUNCTURE; ADOLESCENT; ADULT; ADVERSE OUTCOME; AGED; ALOE VERA; ALTERNATIVE MEDICINE; ARTICLE; CHINESE MEDICINE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COLITIS; CROHN DISEASE; DISEASE COURSE; FEMALE; HOMEOPATHY; HUMAN; HYDROTHERAPY; INDETERMINATE COLITIS; MAJOR CLINICAL STUDY; MALE; OSTEOPATHIC MEDICINE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOTHERAPY; QUESTIONNAIRE; REIKI; RISK FACTOR; TREATMENT RESPONSE; ULCERATIVE COLITIS;

ACUPUNCTURE THERAPY; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALOE; COLITIS, ULCERATIVE; COMPLEMENTARY THERAPIES; CROHN DISEASE; DISEASE PROGRESSION; FEMALE; HOMEOPATHY; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT SATISFACTION; PHYTOTHERAPY; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84866986661     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2012.06.008     Document Type: Article

References (29)

1. Eisemberg D.M., Kessler R.C., Foster C., et al. Unconventional medicine in the United States. Prevalence, costs and patterns of use. New England Journal of Medicine 1993, 328:246-252.
2. Langmedad L., Rampton D.S. Review article: complementary and alternative therapies for inflammatory bowel diseases. Alimentary Pharmacology and Therapeutics 2006, 23:341-349.
3. Rawsthorne P., Shanahan F., Cronin N.C., et al. An international survey of the use of attitudes regarding alternative medicine by patients with inflammatory bowel diseases. American Journal of Gastroenterology 1999, 94:1298-1303.
4. Joos S., Rosemann T., Szecsenyi J.B., et al. Use of complementary and alternative medicine in Germany-a survey of patients with inflammatory bowel disease. BMC Complementary and Alternative Medicine 2006, 6-19.
5. Quattropai C., Ausfled B., Straumann A., et al. Complementary alternative medicine in patients with inflammatory bowel disease: use and attitudes. Scandinavian Journal of Gastroenterology 2003, 38:277-282.
6. Moser G., Tillinger W., Sachs G., et al. Relationship between the use of unconventional therapies and disease-related concerns: a study of patients with inflammatory bowel disease. Journal of Psychosomatic Research 1996, 40:503-509.
7. Garcia-Planella E., Marin L., Domenech E., et al. Use of complementary and alternative medicine and drug abuse in patients with inflammatory bowel disease. Medicina Clinica 2007, 128:45-48.
8. Bertomoro P., Renna S., Cottone M., et al. Regional variations in the use of complementary and alternative medicines (CAM) for inflammatory bowel disease patients in Italy: an IG-IBD study. Journal of Crohn's and Colitis 2010, 4:291-300.
9. Bensoussan M., Jovenin N., Garcia B., et al. Complementary and alternative medicine use by patients with inflammatory bowel disease. Result from a postal survey. Gastroenterologie Clinique et Biologique 2006, 30:14-23.
10. Lakatos P.L., Czegledi Z., David G., et al. Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease. Journal of Crohn's and Colitis 2010, 4:283-290.
11. Langhorst J., Anthonisen I.B., Steder-Neukamm U., et al. Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey. Inflammatory Bowel Diseases 2005, 11:287-295.
12. Langmead L., Chitnis M., Rampton D.S. Use of complementary therapies by patients with IBD may indicate psychosocial distress. Inflammatory Bowel Diseases 2002, 8:174-179.
13. Leong R.W., Lawrance I.C., Ching J.Y., et al. Knowledge, quality of life, and use of complementary alternative medicine and therapies in inflammatory bowel disease: a comparison of Chinese and Caucasian patients. Digestive Diseases and Sciences 2004, 49:1672-1676.
14. Lennard-Jones J.E. Classification of inflammatory bowel disease. Scandinavian Journal of Gastroenterology 1989, 24(Suppl. 170):2-6.
15. Silverberg M.S., Satsangi J., Ahmad T., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal Word Congress of Gastroenterology. Canadian Journal of Gastroenterology 2005, 19(Suppl. A):5-36.
16. Eisenberg D.M., Davis R.B., Ettner S., et al. Trends in alternative medicine use in the United States. Result of a follow-up national survey. The Journal of the American Medical Association 1998, 280:1569-1575.
17. Kessler R.C., Davis R.B., Foster D.F., et al. Long-term trends in the use of complementary and alternative medical therapies in the United States. Annals of Internal Medicine 2001, 135:262-268.
18. Van Assche G., Dignass A., Reinisch, et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: special situations. Journal of Crohn's and Colitis 2010, 4:63-101.
19. Biancone L., Michetti P., Travis S., et al. The second European evidence-based consensus on the diagnosis and management of ulcerative colitis: special situations. Journal of Crohn's and Colitis 2008, 2:63-92.
20. Hilsden R.J., Meddings J.B., Verhoef M.J. Complementary and alternative medicine use by patients with inflammatory bowel disease: an Internet survey. Canadian Journal of Gastroenterology 1999, 13:327-332.
21. Hilsden R.J., Verhoef M.J., Best A., et al. Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey. American Journal of Gastroenterology 2003, 98:1563-1568.
22. Markowitz J.E., Mamula P., delRosario J.F., et al. Patterns of complementary and alternative medicine use in a population of pediatric patients with inflammatory bowel disease. Inflammatory Bowel Diseases 2004, 10:599-605.
23. Weizman A.V., Ahn E., Thanabalan R., et al. Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease. Alimentary Pharmacology and Therapeutics 2012, 35:342-349.
24. Opheim R., Hoivik M., Solberg I., et al. Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (ISBEN). Journal of Crohn's and Colitis 2012, 6:345-353.
25. Renna S., Orlando A., Mocciaro F., et al. Placebo therapy in Crohn's disease. European Journal of Internal Medicine 2009, 20:572-578.
26. De Smet P.A. Herbal remedies. New England Journal of Medicine 2002, 347:12046-12056.
27. Stedman C. Herbal hepatotoxicity. Seminars in Liver Disease 2002, 22:195-206.
28. Breidenbach T., Hoffmann M.W., Becker T., et al. Drug interaction of St John's Wort with cyclosporine. Lancet 2000, 355:1912.
29. Ernst E., Sherman K.J. Is acupuncture a risk factor for hepatitis? Systematic review of epidemiological studies. Journal of Gastroenterology and Hepatology 2003, 18:1231-1236.